Chemoinformaics analysis of 3,5,7-TRIHYDROXY-2-(3-HYDROXY-4-METHOXYPHENYL)CHROMEN-4-ONE
| Molecular Weight | 316.265 | nRot | 2 |
| Heavy Atom Molecular Weight | 304.169 | nRig | 18 |
| Exact Molecular Weight | 316.058 | nRing | 3 |
| Solubility: LogS | -3.74 | nHRing | 1 |
| Solubility: LogP | 2.553 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 40.3355 |
| nHD | 4 | BPOL | 16.3785 |
| QED | 0.572 |
| Synth | 2.47 |
| Natural Product Likeliness | 1.545 |
| NR-PPAR-gamma | 0.957 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.048 |
| HIA | 0.024 |
| CACO-2 | -5.064 |
| MDCK | 0.00000945 |
| BBB | 0.005 |
| PPB | 0.962908 |
| VDSS | 0.646 |
| FU | 0.0809291 |
| CYP1A2-inh | 0.963 |
| CYP1A2-sub | 0.774 |
| CYP2c19-inh | 0.123 |
| CYP2c19-sub | 0.049 |
| CYP2c9-inh | 0.675 |
| CYP2c9-sub | 0.829 |
| CYP2d6-inh | 0.601 |
| CYP2d6-sub | 0.289 |
| CYP3a4-inh | 0.542 |
| CYP3a4-sub | 0.088 |
| CL | 7.014 |
| T12 | 0.914 |
| hERG | 0.058 |
| Ames | 0.611 |
| ROA | 0.07 |
| SkinSen | 0.785 |
| Carcinogencity | 0.036 |
| EI | 0.916 |
| Respiratory | 0.136 |
| NR-Aromatase | 0.898 |
| Antiviral | Yes |
| Prediction | 0.788293 |